Table 2. Number of Manufacturing Units, Sales Units, Inspections and the Actual and Required Numbers of Inspectors in India (2011-2012) and Three Study Districts (Dhule, Nagpur, and Sangli) 2009-2010 .
|
No. of Manufacturing Units
(a) |
No. of Sales Units
ab
(b) |
Expected Inspections Based on Drugs and Cosmetics Act
(c) = a + b |
Actual Inspections Conducted: Actual (% of expected) | No. of Drug Inspectors: Appointed (Sanctioned) |
Drug Inspectors Based on Maharashtra FDA Norm: Number Required (Shortfall %)
(x) = (a/10x12) + (b/21x12) |
Drug Inspectors Based on Mashelkar Committee Norm: Number Required
(Shortfall %) (y) = (a/50) + (b/200) |
|
| India (2011-2012)2 | 10563 | 600000c | 610563 | Data not available | 846 (1349) | 2469 (NA) | 3211 (74) |
|
Maharashtra (2009-2010)10 |
1523a | 80417 | 81940 | 19195 (23) | 73 (161) | 332 (78) | 433 (83) |
| Study districtsd (2009-2010)10 | |||||||
| Dhule | 10a | 2094 | 2104 | 238 (11) | 0 (NA) | 8 (100) | 11 (100) |
| Nagpur | 95a | 4039 | 4134 | 1010 (24) | 4 (6) | 17 (76) | 22 (82) |
| Sangli | 32a | 2225 | 2257 | 246 (11) | 1 (4) | 9 (89) | 12 (92) |
Abbreviations: FDA: Food and Drug Administration; NA, Information not available.
aOnly allopathic units; bSales Units – Retail and whole sale pharmacies, distributors, carrying, and forwarding units. c Estimates; d Segregated data for Mumbai and Mumbai city district is not available.